STOCKSCOUTER

StockScouter Premium

StockScouter Screener and Portfolios are now in our premium offering.
Learn more or Get it now! Stockscouter Portfolio performance

GOSS GOSSAMER BIO INCORPORATED StockScouter® Report

3

StockScouter® Score

GOSSAMER BIO INCORPORATED, a small cap company in the healthcare sector, is expected to slightly underperform the market over the next six months with slightly higher than average risk

10 is the best possible rating. Learn more.

Summary

Positives

  • Earnings growth in the past year has accelerated moderately compared to earnings growth in the past three years. Positive

 

Concerns

  • One or more analysts has modestly decreased quarterly earnings estimates for GOSS. Negative
  • The most recent quarterly earnings report was slightly lower than analysts’ consensus forecast. Neutral/Negative
  • Two or more executives, directors or major shareholders sold a small number of shares recently. Negative

 

Short-term Outlook

Over the next 1-2 months, StockScouter forecasts that small cap stocks will be neutral, stocks will be , and healthcare stocks will be neutral.

Expected Risk/Return

Progress: 80% done.
Progress: 40% done.
Low
High

Core Model Grades

C
D
N/A
A

Previous Ratings

3
2
2